EMBECTA CORP. Depreciation and Amortization
EMBECTA CORP. (EMBC) reported Depreciation and Amortization of $31.10 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-07
- EMBECTA CORP. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $10.60M, a 15.22% increase year-over-year.
- EMBECTA CORP. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $10.20M, a 13.33% increase year-over-year.
- EMBECTA CORP. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $10.30M, a 9.57% increase year-over-year.
- EMBECTA CORP. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $13.10M, a 37.89% increase year-over-year.
- EMBECTA CORP. depreciation, depletion and amortization for fiscal 2025 was $40.70M, a 12.43% increase from fiscal 2024.
- EMBECTA CORP. depreciation, depletion and amortization for fiscal 2024 was $36.20M, a 11.04% increase from fiscal 2023.
- EMBECTA CORP. depreciation, depletion and amortization for fiscal 2023 was $32.60M, a 2.84% increase from fiscal 2022.
- EMBECTA CORP. depreciation, depletion and amortization for fiscal 2022 was $31.70M, a 17.23% decline from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $20.80M derived: sum of 2 quarters · filed 2026-08-07 | $31.10M 10-Q · filed 2026-08-07 | $44.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $20.50M 10-Q · filed 2026-05-05 | $33.60M derived: sum of 3 quarters · filed 2026-05-05 | $42.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $10.30M 10-Q · filed 2026-02-05 | $23.40M derived: sum of 2 quarters · filed 2026-02-05 | $32.60M derived: sum of 3 quarters · filed 2026-08-07 | $41.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-09-30 | $13.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $22.30M derived: sum of 2 quarters · filed 2026-08-07 | $31.30M derived: sum of 3 quarters · filed 2026-08-07 | $40.70M 10-K · filed 2025-11-25 |
| 2025-06-30 | $9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $18.20M derived: sum of 2 quarters · filed 2026-08-07 | $27.60M 10-Q · filed 2026-08-07 | $37.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $18.40M 10-Q · filed 2026-05-05 | $27.90M derived: sum of 3 quarters · filed 2026-05-05 | $36.80M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $9.40M 10-Q · filed 2026-02-05 | $18.90M derived: sum of 2 quarters · filed 2026-02-05 | $27.80M derived: sum of 3 quarters · filed 2026-02-05 | $36.80M derived: sum of 4 quarters · filed 2026-02-05 |
| 2024-09-30 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $18.40M derived: sum of 2 quarters · filed 2025-11-25 | $27.40M derived: sum of 3 quarters · filed 2025-11-25 | $36.20M 10-K · filed 2025-11-25 |
| 2024-06-30 | $8.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $17.90M derived: sum of 2 quarters · filed 2025-08-08 | $26.70M 10-Q · filed 2025-08-08 | $36.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | $17.80M 10-Q · filed 2025-05-09 | $27.10M derived: sum of 3 quarters · filed 2025-11-25 | $35.20M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $8.80M 10-Q · filed 2025-02-06 | $18.10M derived: sum of 2 quarters · filed 2025-11-25 | $26.20M derived: sum of 3 quarters · filed 2025-11-25 | $34.20M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $9.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $17.40M derived: sum of 2 quarters · filed 2025-11-25 | $25.40M derived: sum of 3 quarters · filed 2025-11-25 | $32.60M 10-K · filed 2025-11-25 |
| 2023-06-30 | $8.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $16.10M derived: sum of 2 quarters · filed 2024-08-09 | $23.30M 10-Q · filed 2024-08-09 | $30.80M derived: sum of 4 quarters · filed 2024-12-11 |
| 2023-03-31 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $15.20M 10-Q · filed 2024-05-09 | $22.70M derived: sum of 3 quarters · filed 2024-12-11 | $31.80M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $7.20M 10-Q · filed 2024-02-09 | $14.70M derived: sum of 2 quarters · filed 2024-12-11 | $23.80M derived: sum of 3 quarters · filed 2024-12-11 | $30.50M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-09-30 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $16.60M derived: sum of 2 quarters · filed 2024-12-11 | $23.30M derived: sum of 3 quarters · filed 2024-12-11 | $31.70M 10-K · filed 2024-12-11 |
| 2022-06-30 | $9.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $15.80M derived: sum of 2 quarters · filed 2023-08-08 | $24.20M 10-Q · filed 2023-08-08 | $33.10M derived: sum of 4 quarters · filed 2023-11-29 |
| 2022-03-31 | $6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $15.10M 10-Q · filed 2023-05-12 | $24.00M derived: sum of 3 quarters · filed 2023-11-29 | $33.90M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-12-31 | $8.40M 10-Q · filed 2023-02-14 | $17.30M derived: sum of 2 quarters · filed 2023-11-29 | $27.20M derived: sum of 3 quarters · filed 2023-11-29 | $37.40M derived: sum of 4 quarters · filed 2023-11-29 |
| 2021-09-30 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $18.80M derived: sum of 2 quarters · filed 2023-11-29 | $29.00M derived: sum of 3 quarters · filed 2023-11-29 | $38.30M 10-K · filed 2023-11-29 |
| 2021-06-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $20.10M derived: sum of 2 quarters · filed 2022-08-15 | $29.40M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $19.50M 10-Q · filed 2022-05-13 | ||
| 2020-12-31 | $9.30M 10-Q · filed 2022-03-16 | |||
| 2020-09-30 | $38.30M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |